Results 151 to 160 of about 189,627 (209)
Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange. [PDF]
Tupin F +6 more
europepmc +1 more source
Bleeding Disorders in Children With Genetic Diseases: A Narrative Review. [PDF]
Cagol R +6 more
europepmc +1 more source
Comparison of Two Artificial Liver Treatments for Acute Liver Failure: A Retrospective Observational Study. [PDF]
Wu X +6 more
europepmc +1 more source
Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia. [PDF]
Morelli F +5 more
europepmc +1 more source
[Blood coagulation disorders in obstetrics].
S, Karchmer, M, Gitler
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Blood Coagulation and Hemophilioid Disorders
Postgraduate Medicine, 1968Hereditary bleeder states and syndromes of diffuse intravascular clotting are considered from the standpoint of laboratory diagnosis and the physiologic principles on which management is based. Availability of antihemophilic factor concentrates has revolutionized treatment of hemophilia A.
H R, Roberts, K M, Brinkhous
openaire +2 more sources
[Blood coagulation disorders].
Schweizerische medizinische Wochenschrift, 1987Disorders of hemostasis are frequently encountered, and, if not recognised as early as possible, in particular prior to surgery, may lead to bleeding complications which are much more difficult to treat than those where exact diagnosis permits specific preventive therapy.
openaire +3 more sources
Blood coagulation disorders in septic patients
Wiener Medizinische Wochenschrift, 2010Host defense and blood coagulation are tightly connected and interacting systems, necessary for the integrity of an organism. Complex mechanisms regulate the intensity of a host response to invading pathogens or other potentially dangerous situations.
openaire +2 more sources
[Acquired blood coagulation disorders].
Hamostaseologie, 2005Acquired coagulopathies regularly result from underlying diseases such as liver failure or sepsis. Optimal treatment of these underlying diseases defines longterm prognosis. In a few coagulopathies, such as immunocoagulopathies, in a relevant portion of patients an underlying disease cannot be identified. Therapeutic modulation of haemostasis aiming at
openaire +1 more source

